NWBO are about to publish PIII data on a platform for all solid tumors yet you're coming here shilling preclinical mouse studies?
Platform? Not a single patient responded to Direct and there won't be data from the PhIII (in a small indication) anytime soon. As for PACT Pharma, they are in the clinic and working on next-gen versions.